Mastering Clinical Challenges in IBD 2022

Saturday, May 7, 2022, 7:00 AM - 4:00 PM, Ritz Carlton, Mclean, VA

Online registration for Mastering Clinical Challenges in IBD 2022 is now closed. Onsite registration will be available starting at 7:30 a.m.

The incidence of inflammatory bowel disease (IBD) continues to rise in the world, and now affects more than 3.1 million Americans. We currently have a better understanding of the pathogenesis of IBD, allowing for the development of new therapies targeting the inflammatory pathways. Hence, the management of this complex disease is in turn becoming complex, in which the clinician needs to use evidence-based medicine to personalize the use of the appropriate therapy for each individual patient. Becoming familiar with treat-to-target and disease modification strategies is essential to maximize the therapeutic benefit of therapies and the chance of maintaining IBD patients in remission and preventing complications. Patients with long standing IBD carry an increased risk of colon cancer, and the IBD therapies available have potential side effects. It is essential for healthcare providers to use current guidelines in prevention and screening of these complications to maximize patients’ health and the quality of care. IBD not only affects the gastrointestinal tract, but also several extra-intestinal organ systems, often requiring a multidisciplinary approach to the patients involving several medicine specialties, colorectal surgery and radiology as well as nutrition support.

The purpose of this symposium is to provide up-to-date information on the pathogenesis of the disease process, as well as evidence-based recommendations on the management and monitoring of IBD and related inflammatory disorders. Through this course, the gap between state-of-the-art practice and current practices will be closed to provide a high quality, comprehensive, multidisciplinary approach to patients with IBD. We believe this approach will improve the quality of care provided to patients, decrease the risk of complications and morbidity, and reduce the overall burden of IBD on the patient and society. We will be utilizing a novel framework of mentor experts and mentee case presentations during this symposium. We will also be discussing state of the art lectures in training needs, artificial intelligence, and underrepresentation in IBD.

 

Endorsed by:

       

1. Implement quality measures in your clinical practice.
2. Implement the use of biosimilars in the treatment of IBD.
3. Identify the mechanism of action of small molecules and appropriately position them in the treatment of IBD.
4. Optimize and maximize existing therapies through therapeutic drug monitoring.
5. Analyze the management of the pregnant patient with IBD including management of the medications and disease process.
6. Identify other diseases that may mimic IBD.
7. Recognize and successfully manage rheumatologic manifestations in IBD.
8. Recognize and successfully manage hepatobiliary complications in IBD.
9. Recognize the advanced surgical procedures available for perianal disease.
10. Recognize and implement the appropriate timing of surgical intervention in the management of IBD.
11. Apply a multidisciplinary approach when treating IBD and its complications.
12. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with IBD.
13. Integrate a team-based approach in the care of patients with IBD.

Physician  $125
Resident or Fellow  $0
Physician Assistant  $75
Nurse Practitioner  $75
Nurse  $75
Allied Health Professional     $75
Pharmacist     $75
Industry Professional     $300

Accreditation
In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 5.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physicians: MedStar Health designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 5.25 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

 

 

Pharmacist/Pharmacy Technicians: This activity is approved for 5.25 contact hours. This learning activity is knowledge-based. The Universal Activity Number for this program is UAN # JA4008151-0000-22-067-L04-P/ JA4008151-0000-22-067-L04-T

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:


5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and




5.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and




  5.25 MOC points in the American Board of Surgery’s (ABS) Maintenance of Certification (MOC) program


It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM, ABP, and/or ABS credit. Credit will be reported within 30 days of claiming credit.

 

AMA PRA Category 1 Credits™ Physician (5.25 hours), ABIM MOC Part 2 (5.25 hours), ABP MOC Part 2 (5.25 hours), ABS CC (5.25 hours), IPCE (5.25 hours), Non-Physician Member of the Healthcare Team (5.25 hours), Nurse - ANCC (5.25 hours), Pharmacist - ACPE (5.25 hours), Physician Assistant - AAPA (5.25 hours)

The Ritz-Carlton, Tysons Corner 1700 Tysons Blvd. McLean, VA

703-506-4300

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, May 7, 2022

Please contact Ada Guo at [email protected] for information on exhibiting at this conference.

Your health and safety are MedStar Health, Inc.’s top priority, and we are taking the necessary precautions to make ensure this year’s events are safe as we continue to face the challenges of COVID-19.

Mastering Clinical Challenges in IBD is committed to providing a welcoming and safe learning environment while cautiously planning for a live conference. We will continue to monitor federal, state and local recommendations and will update these protocols and measures as appropriate.

We reserve the right to modify these policies and procedures at any time given the rapidly changing nature of the current global pandemic.

General safety and wellness measures include but are not limited to:

• Hand sanitizing stations throughout public areas
• Cleaning between sessions
• Signage posted with reminders for physical distancing and hand washing

Mask Requirement

Fairfax County Health Department recommends that everyone, including individuals fully vaccinated against COVID-19, wear a mask in public indoor settings.

Venue

As part of our Connect with Confidence initiatives, Marriott strongly encourages our associates to be vaccinated for COVID 19.  Through Marriott’s Vaccination Care Program, a financial award is provided to US hotel associates at managed properties who get vaccinated.  However, vaccination is not mandatory and information on vaccination status is shared by our associates on a voluntary basis.

For more information regarding the hotel and COVID please visit the Ritz-Carlton Website

COVID-19 Assumption of Risk, Waiver and Compliance Commitment
I am aware of the inherent risk of exposure to the COVID-19 virus involved in attending the in-person Mastering Clinical Challenges in IBD conference and that COVID-19 is a highly contagious disease that can lead to sever illness and death. I voluntarily assume all risks related to exposure to COVID-19 when attending MedStar Health, Inc. related conferences and waive liability against MedStar Health, Inc., it’s associates, directors, contractors and staff for any loss, damages, or suffering relating to exposure to COVID-19.

Daily Self Health Screening

Mastering Clinical Challenges in IBD recommends that all participants screen themselves daily for symptoms. Symptoms may appear 2 – 14 days after exposure to the virus. The following symptoms are outlined on the CDC Website indicating an individual may have COVID-19:

• Fever or chills
• Cough
• Shortness of breath or difficulty breathing
• Fatigue
• Muscle or body aches
• Headache
• New loss of taste or smell
• Sore throat
• Congestion or runny nose
• Nausea or vomiting
• Diarrhea

Individuals who have these symptoms and are unwell should not attend the BC3 Conference. Additionally, if the person is onsite, affected individuals should notify event organizers to allow for additional communication to participants.

TRAVEL TO THE U.S.

Effective December 2, 2021, all travelers to the U.S. must show proof of full vaccination and a negative COVID-19 test, taken within 1 day, prior to boarding their flight to the U.S. Those traveling by land do not need to provide a negative test. For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. Existing visa policies remain in place. Please check back regularly for the latest information.
(As of December 2, 2021)

Additional Resources

·         Centers for Disease Control and Prevention

·         World Health Organization

 

We thank you for your continued support and look forward to welcoming you to Mastering Clinical Challenges in IBD in May.